oxcarbazepine
Generic: oxcarbazepine
Labeler: zydus lifesciences limitedDrug Facts
Product Profile
Brand Name
oxcarbazepine
Generic Name
oxcarbazepine
Labeler
zydus lifesciences limited
Dosage Form
TABLET
Routes
Active Ingredients
oxcarbazepine 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
70771-1843
Product ID
70771-1843_905fd0b0-fd53-48f5-83ff-129a5f5f104c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA211747
Listing Expiration
2026-12-31
Marketing Start
2025-07-10
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
707711843
Hyphenated Format
70771-1843
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
oxcarbazepine (source: ndc)
Generic Name
oxcarbazepine (source: ndc)
Application Number
ANDA211747 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 1000 TABLET in 1 BOTTLE (70771-1843-0)
- 100 TABLET in 1 BOTTLE (70771-1843-1)
- 10 BLISTER PACK in 1 CARTON (70771-1843-4) / 10 TABLET in 1 BLISTER PACK
- 500 TABLET in 1 BOTTLE (70771-1843-5)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "905fd0b0-fd53-48f5-83ff-129a5f5f104c", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0370771184415", "0370771184217", "0370771184316"], "unii": ["VZI5B1W380"], "rxcui": ["312136", "312137", "312138"], "spl_set_id": ["e23d8a74-b47b-462a-b09c-90bdd58a032e"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (70771-1843-0)", "package_ndc": "70771-1843-0", "marketing_start_date": "20250710"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (70771-1843-1)", "package_ndc": "70771-1843-1", "marketing_start_date": "20250710"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (70771-1843-4) / 10 TABLET in 1 BLISTER PACK", "package_ndc": "70771-1843-4", "marketing_start_date": "20250710"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (70771-1843-5)", "package_ndc": "70771-1843-5", "marketing_start_date": "20250710"}], "brand_name": "oxcarbazepine", "product_id": "70771-1843_905fd0b0-fd53-48f5-83ff-129a5f5f104c", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70771-1843", "generic_name": "oxcarbazepine", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "300 mg/1"}], "application_number": "ANDA211747", "marketing_category": "ANDA", "marketing_start_date": "20250710", "listing_expiration_date": "20261231"}